rs41302834

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_032119.4(ADGRV1):​c.5830G>A​(p.Asp1944Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00588 in 1,613,812 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D1944Y) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0043 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0060 ( 34 hom. )

Consequence

ADGRV1
NM_032119.4 missense

Scores

5
6
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 9.87

Publications

12 publications found
Variant links:
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]
ADGRV1 Gene-Disease associations (from GenCC):
  • Usher syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 2C
    Inheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • febrile seizures, familial, 4
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00907135).
BP6
Variant 5-90683751-G-A is Benign according to our data. Variant chr5-90683751-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 46342.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0043 (655/152170) while in subpopulation AMR AF = 0.00668 (102/15276). AF 95% confidence interval is 0.00563. There are 5 homozygotes in GnomAd4. There are 303 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADGRV1NM_032119.4 linkc.5830G>A p.Asp1944Asn missense_variant Exon 28 of 90 ENST00000405460.9 NP_115495.3 Q8WXG9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADGRV1ENST00000405460.9 linkc.5830G>A p.Asp1944Asn missense_variant Exon 28 of 90 1 NM_032119.4 ENSP00000384582.2 Q8WXG9-1

Frequencies

GnomAD3 genomes
AF:
0.00431
AC:
655
AN:
152050
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00109
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00669
Gnomad ASJ
AF:
0.0164
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00229
Gnomad FIN
AF:
0.00217
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00589
Gnomad OTH
AF:
0.00622
GnomAD2 exomes
AF:
0.00433
AC:
1077
AN:
248838
AF XY:
0.00425
show subpopulations
Gnomad AFR exome
AF:
0.00129
Gnomad AMR exome
AF:
0.00354
Gnomad ASJ exome
AF:
0.0145
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00200
Gnomad NFE exome
AF:
0.00578
Gnomad OTH exome
AF:
0.00464
GnomAD4 exome
AF:
0.00605
AC:
8840
AN:
1461642
Hom.:
34
Cov.:
33
AF XY:
0.00590
AC XY:
4292
AN XY:
727098
show subpopulations
African (AFR)
AF:
0.000986
AC:
33
AN:
33478
American (AMR)
AF:
0.00322
AC:
144
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0146
AC:
381
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39690
South Asian (SAS)
AF:
0.00231
AC:
199
AN:
86258
European-Finnish (FIN)
AF:
0.00245
AC:
131
AN:
53396
Middle Eastern (MID)
AF:
0.00312
AC:
18
AN:
5768
European-Non Finnish (NFE)
AF:
0.00681
AC:
7569
AN:
1111838
Other (OTH)
AF:
0.00603
AC:
364
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
526
1051
1577
2102
2628
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
304
608
912
1216
1520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00430
AC:
655
AN:
152170
Hom.:
5
Cov.:
32
AF XY:
0.00407
AC XY:
303
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.00108
AC:
45
AN:
41526
American (AMR)
AF:
0.00668
AC:
102
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0164
AC:
57
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00229
AC:
11
AN:
4808
European-Finnish (FIN)
AF:
0.00217
AC:
23
AN:
10596
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00590
AC:
401
AN:
68016
Other (OTH)
AF:
0.00615
AC:
13
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
35
70
104
139
174
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00572
Hom.:
14
Bravo
AF:
0.00415
TwinsUK
AF:
0.00782
AC:
29
ALSPAC
AF:
0.00597
AC:
23
ESP6500AA
AF:
0.00130
AC:
5
ESP6500EA
AF:
0.00724
AC:
60
ExAC
AF:
0.00400
AC:
483
EpiCase
AF:
0.00643
EpiControl
AF:
0.00652

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
May 05, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ADGRV1: BS2 -

Nov 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25262649, 21569298, 30245029, 32707200) -

Nov 07, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
Apr 10, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Asp1944Asn in exon 28 of GPR98: This variant is not expected to have clinical si gnificance because it has been identified in 0.7% (50/6688) of European American chromosomes in a broad population by the NHLBI Exome sequencing project (http:/ /evs.gs.washington.edu/EVS/; dbSNP rs41302834). -

Jun 27, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 25, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 2C Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.40
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.45
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.17
T;T;.
Eigen
Pathogenic
0.84
Eigen_PC
Pathogenic
0.82
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.93
.;D;D
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.0091
T;T;T
MetaSVM
Benign
-0.83
T
PhyloP100
9.9
PrimateAI
Uncertain
0.52
T
PROVEAN
Uncertain
-3.2
.;D;.
REVEL
Benign
0.29
Sift
Uncertain
0.026
.;D;.
Sift4G
Pathogenic
0.0
.;D;.
Polyphen
1.0
D;D;.
Vest4
0.75
MVP
0.75
MPC
0.31
ClinPred
0.019
T
GERP RS
5.7
Varity_R
0.50
gMVP
0.74
Mutation Taster
=45/55
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41302834; hg19: chr5-89979568; API